Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L E Robertson

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Blood|August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapyS O'Brien, H Kantarjian, M Beran, et al.
Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Seminars in Oncology|October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapiesW Plunkett, V Gandhi, P Huang, et al.
Blood|September 15, 1993
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatmentS O'Brien, H Kantarjian, M Beran, et al.
Leukemia & Lymphoma|October 1, 1996
Hodgkin's disease variant of Richter's syndrome: experience at a single institutionL Fayad, L E Robertson, S O'Brien, et al.
Leukemia & Lymphoma|May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysisL E Robertson, R Hall, M J Keating, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Blood|August 15, 1995
Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapyS O'Brien, H Kantarjian, M Beran, et al.
Blood|January 1, 1993
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenineL E Robertson, S Chubb, R E Meyn, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabineL E Robertson, A W Denny, Y O Huh, et al.
Leukemia|June 1, 1995
Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Leukemia & Lymphoma|March 18, 2000
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemiaM J Keating, T L Smith, S Lerner, et al.
Seminars in Oncology|October 1, 1993
Fludarabine: pharmacokinetics, mechanisms of action, and rationales for combination therapiesW Plunkett, V Gandhi, P Huang, et al.
Blood|September 15, 1993
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatmentS O'Brien, H Kantarjian, M Beran, et al.
Leukemia & Lymphoma|October 1, 1996
Hodgkin's disease variant of Richter's syndrome: experience at a single institutionL Fayad, L E Robertson, S O'Brien, et al.
Leukemia & Lymphoma|May 1, 1993
High-dose cytosine arabinoside in chronic lymphocytic leukemia: a clinical and pharmacologic analysisL E Robertson, R Hall, M J Keating, et al.
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.
Pageof 5